Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Research and Markets: Mexico Orthopedic Devices Market Outlook to 2018 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others

November 23, 2012 7:19 am | by The Associated Press | News | Comments

DUBLIN--(BUSINESS WIRE)--Nov 23, 2012--Research and Markets ( http://www.researchandmarkets.com/research/9l27mw/mexico_orthopedic ) has announced the addition of GlobalData's new report "Mexico Orthopedic Devices Market Outlook to 2018 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip...

Endotach sues Medtronic over stent graft patents

November 23, 2012 7:00 am | by Mass Device | News | Comments

Endotach LLC sues Medtronic, alleging infringement of a pair of patents covering stent graft technology by the medical device company's Talent, Valiant and Endurant devices. Medtronic (NYSE:MDT) infringes a pair of patents licensed to Endotach LLC with 3 of its stent grafts for treating abdominal aortic aneurysms, according to a lawsuit filed by Endotach against the medtech titan. The Frisco, Texas-based company holds the exclusive license to the duo of patents from their inventor's widow, according to court documents. Legal News, News Well, Patent Infringement, Stent Graftsread more

CDRH Fiscal Year 2013 (FY 2013) Proposed Guidance Development

November 23, 2012 12:00 am | by U.S. Food & Drug Administration | News | Comments

The lists below include guidance documents that CDRH intends to publish this fiscal year (FY2013). We have provided two lists: (1) a list of guidance documents that the Agency fully intends to publish (the ?A-list?); and (2) a list of guidance...

TOPICS:
Advertisement

bioMérieux and Quanterix sign strategic partnership

November 22, 2012 7:40 am | by I-Micronews | News | Comments

bioMérieux and Quanterix sign strategic partnership in Ultrasensitive and Multiplex Immunoassays.

TOPICS:

Nanotech device Mimics dog's nose to detect explosives

November 22, 2012 7:29 am | by I-Micronews | News | Comments

Portable, accurate, and highly sensitive devices that sniff out vapors from explosives and other substances could become as commonplace as smoke detectors in public places, thanks to researchers at University of California, Santa Barbara.

National Institute for Health and Clinical Excellence Recommends Covidien’s BIS Brain Monitoring System

November 22, 2012 4:00 am | by The Associated Press | News | Comments

BOULDER, Colo.--(BUSINESS WIRE)--Nov 22, 2012--Covidien, a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today announced that the UK-based National Institute for Health and Clinical Excellence (NICE) recommends the use...

MEDIAN Technologies to take part in The Annual 2012 Conference of RSNA in Chicago

November 22, 2012 1:30 am | by The Associated Press | News | Comments

SOPHIA ANTIPOLIS, France--(BUSINESS WIRE)--Nov 22, 2012--Regulatory News: MEDIAN Technologies (Paris:ALMDT), a leading medical imaging software developer and service provider for oncology clinical trials and routine radiological practice, will participate in the 98 th Annual Meeting of the...

Concord Medical to Hold Annual General Meeting on December 22, 2012

November 21, 2012 2:38 pm | by Bio-Medicine.Org | News | Comments

BEIJING, Nov. 21, 2012 /- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM ), a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China and the parent of Chang'an Hospital,, today announced that it will hold its annual general meeting of sh...

Advertisement

ResMed Inc. Announces Exchange Rate For Upcoming Dividend Payment

November 21, 2012 2:31 pm | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Nov. 21, 2012 /- ResMed Inc. (NYSE: RMD ) today announced that the dividend to be paid on December 18, 2012, to holders of Chess Depositary Instruments (CDIs) trading on the Australian Securities Exchange will be Australian dollar $0.01636 per CDI.  (Logo: http://photos.prnewswire.com/prnh/20100203/RESMEDLOGO ) ResMed previously declared a quarterly dividend...

Computer-navigated total knee replacement provides no advantage over traditional surgical procedure

November 21, 2012 1:39 pm | by Bio-Medicine.Org | News | Comments

ROSEMONT, Ill., Nov. 21, 2012 /PRNewswire-USNewswire/ -- For many years, the use of computer-assisted navigation has been touted as improving the positioning, sizing and alignment of replacement knee joints, resulting in greater durability of joints and overall improvement in patient movement. However, new research published in the Journal of Bone and Joint Surgery (JBJS) found no differen...

Mauna Kea Technologies Announces the Signature of a Strategic Partnership With University of Edinburgh for Novel Optical Biopsy Device for Pulmonary Applications

November 21, 2012 11:45 am | by The Associated Press | News | Comments

Mauna Kea Technologies (EURONEXT PARIS: MKEA), leader in the optical biopsy market and developer of Cellvizio®, the fastest way to see cancer, today announced that it has entered into a research agreement through a collaboration negotiated by Edinburgh BioQuarter and the University of...

FDA slams St. Jude Medical over Durata pacemaker leads

November 21, 2012 11:29 am | by Mass Device | News | Comments

St. Jude Medical shares are down 11% today after the FDA releases a report slamming the company over its Durata pacemaker leads. The FDA yesterday released a report on a St. Jude Medical (NYSE:STJ) plant in Sylmar, Calif., that makes its Durata pacemaker leads, finding 11 problems with the plant after inspections in September and October. News Well, Cardiac Rhythm Management, Regulatory/Complianceread more

Boston Scientific lands Euro nod for extended heart implant battery life

November 21, 2012 11:29 am | by Mass Device | News | Comments

European regulators approve updated labeling for several of Boston Scientific's implantable cardiac devices to reflect battery life potentials that the company says double some rival devices. Medical devices giant Boston Scientific (NYSE:BSX) this week won CE Mark approval in the European Union for updated labeling on several models of its implantable cardiac devices in recognition of battery life projections of up to 10 years in some cases. News Well, Cardiac Implants, CE Mark, Regulatory/Complianceread more

Thoratec Presentation At Piper Jaffray 24th Annual Healthcare Conference To Be Webcast

November 21, 2012 11:25 am | by Bio-Medicine.Org | News | Comments

PLEASANTON, Calif., Nov. 21, 2012 /- Thoratec Corporation (NASDAQ: THOR ), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in the Piper Jaffray 24 th Annual Healthcare Conference on Tuesday, November 27. Gary F. Burbach, President and Chief Executive Officer, will provide an...

Mako Surgical closes $43 million public offering

November 21, 2012 10:29 am | by Mass Device | News | Comments

Florida surgical devices maker Mako Surgical closes an $40 million fundraising round with an extra $3 million in tow. Fort Lauderdale-based medical device maker Mako Surgical (NSDQ:MAKO) closed the books on a $40 million funding round with an extra $3 million in net proceeds, the company announced. Mako said last week that the offering, priced at $13.15 per share for more than 3 million shares, would go toward "commercialization infrastructure" and to cover other corporate expenses. News Well, Robotic Assisted Surgery, Wall Street Beatread more

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading